SCHEMBL8632170

SCHEMBL8632170

CCCCc1nc2ccc(C(=O)OC)cc2[nH]1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.64
GAA P10253 1/20 0.64
PKM P14618 1/20 0.64
LMNA P02545 2/20 0.56
ALDH1A1 P00352 2/20 0.56
KDM4E B2RXH2 1/20 0.56
HTT P42858 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
APEX1 P27695 1/20 0.52
MAPK1 P28482 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
TUBB4A P04350 1/20 0.51
CYP1A2 P05177 1/20 0.51
TUBB P07437 1/20 0.51
TUBA3C P0DPH7 1/20 0.51
CYP2D6 P10635 1/20 0.51
TSHR P16473 1/20 0.51
TUBA1B P68363 1/20 0.51
TUBA4A P68366 1/20 0.51
TUBB4B P68371 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7338079 0.95 MAPT (0.61) MAPTGAAPKMLMNAALDH1A1
SCHEMBL6015473 0.92 MAPT (0.60) MAPTGAAPKMLMNAALDH1A1
SCHEMBL8632161 0.90 MAPT (0.55) MAPTGAAPKMALDH1A1L3MBTL1
SCHEMBL1206622 0.87 MAPT (0.56) MAPTGAAPKMLMNAALDH1A1
SCHEMBL14347066 0.87 ALDH1A1 (0.61) MAPTGAAPKMLMNAALDH1A1
SCHEMBL8906012 0.85 APEX1 (0.71) MAPTALDH1A1APEX1MAPK1SMN1; SMN2
SCHEMBL7338067 0.85 MAPT (0.53) MAPTGAAPKML3MBTL1MAPK1
SCHEMBL18229547 0.85 HDAC6 (0.68) MAPTGAAPKMALDH1A1APEX1
SCHEMBL13931450 0.84 NPSR1 (0.68) MAPTGAAPKMLMNAALDH1A1
SCHEMBL24329791 0.83 ALDH1A1 (0.60) MAPTGAAPKMLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0603001-B1 Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease SANKYO CO (JP) 1998-08-26 EP disclosed
US-5459148-A Cardiovascular disorders SANKYO COMPANY, LIMITED (JP) 1995-10-17 US disclosed
EP-0603001-A1 Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease SANKYO COMPANY LIMITED (JP) 1994-06-22 EP disclosed
EP-0400835-A1 Substituted benzimidazoles as angiotensin II antagonists MERCK & CO. INC. (US) 1990-12-05 EP disclosed
US-4880804-A HYPOTENSIVE AGENTS, CONGESTIVE HEART FAILURE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-11-14 US disclosed